Teladoc Historical Income Statement

TDOC Stock

USD 8.41 0.24 2.94%

Historical analysis of Teladoc income statement accounts such as Total Revenue of 2.7 B, Gross Profit of 1.9 B, Other Operating Expenses of 3.8 B or Research Development of 322.6 M can show how well Teladoc performed in making a profits. Evaluating Teladoc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Teladoc's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Teladoc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Teladoc is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

About Teladoc Income Statement Analysis

Teladoc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Teladoc shareholders. The income statement also shows Teladoc investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Teladoc Income Statement Chart

At present, Teladoc's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.7 B, whereas Selling General Administrative is forecasted to decline to about 256.2 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Other Operating Expenses Cost Of Revenue

Total Revenue

Total revenue comprises all receipts Teladoc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Teladoc. It is also known as Teladoc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Teladoc income statement and represents the costs associated with goods and services Teladoc provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Teladoc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.7 B, whereas Selling General Administrative is forecasted to decline to about 256.2 M.

	2022	2023	2024	2025 (projected)
Interest Expense	9.3M	22.3M	23.8M	25.2M
Depreciation And Amortization	270.6M	351.3M	382.8M	402.0M

Interest Expense Depreciation And Amortization

Teladoc income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Non Recurring	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items	Non Operating Income Net Other
Depreciation And Amortization		0.38	0.78	0.87	0.98	0.99	0.99	-0.36	-0.35	0.95	-0.31	0.97	0.99	-0.35	-0.27	-0.35	0.21	-0.35	0.93	0.21	0.79	0.36	0.94	-0.67	0.23
Interest Expense	0.38		0.71	0.51	0.49	0.47	0.48	0.07	0.07	0.55	0.09	0.54	0.46	0.06	0.11	0.06	-0.12	0.06	0.05	-0.12	0.13	-0.67	0.37	-0.09	-0.59
Selling General Administrative	0.78	0.71		0.93	0.87	0.86	0.84	-0.41	-0.41	0.9	-0.38	0.89	0.81	-0.41	-0.35	-0.41	-0.21	-0.41	0.61	-0.21	0.43	-0.18	0.83	-0.23	-0.02
Selling And Marketing Expenses	0.87	0.51	0.93		0.93	0.92	0.87	-0.52	-0.52	0.95	-0.49	0.94	0.84	-0.52	-0.47	-0.52	0.09	-0.52	0.75	0.09	0.52	0.03	0.95	-0.23	0.06
Total Revenue	0.98	0.49	0.87	0.93		1.0	0.99	-0.43	-0.43	0.99	-0.39	1.0	0.98	-0.43	-0.35	-0.43	0.14	-0.43	0.88	0.14	0.7	0.2	0.94	-0.57	0.14
Gross Profit	0.99	0.47	0.86	0.92	1.0		0.99	-0.43	-0.42	0.99	-0.38	1.0	0.98	-0.43	-0.35	-0.43	0.15	-0.43	0.89	0.15	0.72	0.22	0.95	-0.58	0.16
Other Operating Expenses	0.99	0.48	0.84	0.87	0.99	0.99		-0.37	-0.37	0.97	-0.33	0.98	1.0	-0.37	-0.28	-0.37	0.1	-0.37	0.9	0.1	0.75	0.25	0.92	-0.68	0.19
Operating Income	-0.36	0.07	-0.41	-0.52	-0.43	-0.43	-0.37		1.0	-0.46	1.0	-0.45	-0.35	1.0	0.99	1.0	0.01	1.0	-0.48	0.01	-0.03	-0.04	-0.4	0.0	-0.27
Ebit	-0.35	0.07	-0.41	-0.52	-0.43	-0.42	-0.37	1.0		-0.45	1.0	-0.44	-0.34	1.0	1.0	1.0	0.02	1.0	-0.47	0.02	-0.02	-0.03	-0.4	-0.01	-0.27
Research Development	0.95	0.55	0.9	0.95	0.99	0.99	0.97	-0.46	-0.45		-0.41	1.0	0.95	-0.46	-0.38	-0.46	0.13	-0.46	0.83	0.13	0.62	0.1	0.93	-0.49	0.06
Ebitda	-0.31	0.09	-0.38	-0.49	-0.39	-0.38	-0.33	1.0	1.0	-0.41		-0.4	-0.3	1.0	1.0	1.0	0.03	1.0	-0.43	0.03	0.02	-0.01	-0.36	-0.04	-0.26
Cost Of Revenue	0.97	0.54	0.89	0.94	1.0	1.0	0.98	-0.45	-0.44	1.0	-0.4		0.97	-0.45	-0.37	-0.45	0.1	-0.45	0.85	0.1	0.67	0.14	0.93	-0.54	0.11
Total Operating Expenses	0.99	0.46	0.81	0.84	0.98	0.98	1.0	-0.35	-0.34	0.95	-0.3	0.97		-0.34	-0.25	-0.34	0.1	-0.34	0.9	0.1	0.77	0.28	0.91	-0.71	0.21
Income Before Tax	-0.35	0.06	-0.41	-0.52	-0.43	-0.43	-0.37	1.0	1.0	-0.46	1.0	-0.45	-0.34		0.99	1.0	0.02	1.0	-0.47	0.02	-0.02	-0.02	-0.4	-0.01	-0.26
Total Other Income Expense Net	-0.27	0.11	-0.35	-0.47	-0.35	-0.35	-0.28	0.99	1.0	-0.38	1.0	-0.37	-0.25	0.99		0.99	0.01	0.99	-0.39	0.01	0.05	0.01	-0.33	-0.09	-0.24
Net Income	-0.35	0.06	-0.41	-0.52	-0.43	-0.43	-0.37	1.0	1.0	-0.46	1.0	-0.45	-0.34	1.0	0.99		0.01	1.0	-0.47	0.01	-0.02	-0.02	-0.4	-0.01	-0.26
Income Tax Expense	0.21	-0.12	-0.21	0.09	0.14	0.15	0.1	0.01	0.02	0.13	0.03	0.1	0.1	0.02	0.01	0.01		0.01	0.14	1.0	0.16	0.21	0.21	-0.15	-0.35
Net Income From Continuing Ops	-0.35	0.06	-0.41	-0.52	-0.43	-0.43	-0.37	1.0	1.0	-0.46	1.0	-0.45	-0.34	1.0	0.99	1.0	0.01		-0.47	0.01	-0.02	-0.02	-0.4	-0.01	-0.26
Non Recurring	0.93	0.05	0.61	0.75	0.88	0.89	0.9	-0.48	-0.47	0.83	-0.43	0.85	0.9	-0.47	-0.39	-0.47	0.14	-0.47		0.14	0.81	0.61	0.86	-0.69	0.54
Tax Provision	0.21	-0.12	-0.21	0.09	0.14	0.15	0.1	0.01	0.02	0.13	0.03	0.1	0.1	0.02	0.01	0.01	1.0	0.01	0.14		0.16	0.2	0.21	-0.15	-0.35
Interest Income	0.79	0.13	0.43	0.52	0.7	0.72	0.75	-0.03	-0.02	0.62	0.02	0.67	0.77	-0.02	0.05	-0.02	0.16	-0.02	0.81	0.16		0.58	0.67	-0.74	0.49
Net Interest Income	0.36	-0.67	-0.18	0.03	0.2	0.22	0.25	-0.04	-0.03	0.1	-0.01	0.14	0.28	-0.02	0.01	-0.02	0.21	-0.02	0.61	0.2	0.58		0.28	-0.53	0.78
Reconciled Depreciation	0.94	0.37	0.83	0.95	0.94	0.95	0.92	-0.4	-0.4	0.93	-0.36	0.93	0.91	-0.4	-0.33	-0.4	0.21	-0.4	0.86	0.21	0.67	0.28		-0.42	0.17
Extraordinary Items	-0.67	-0.09	-0.23	-0.23	-0.57	-0.58	-0.68	0.0	-0.01	-0.49	-0.04	-0.54	-0.71	-0.01	-0.09	-0.01	-0.15	-0.01	-0.69	-0.15	-0.74	-0.53	-0.42		-0.33
Non Operating Income Net Other	0.23	-0.59	-0.02	0.06	0.14	0.16	0.19	-0.27	-0.27	0.06	-0.26	0.11	0.21	-0.26	-0.24	-0.26	-0.35	-0.26	0.54	-0.35	0.49	0.78	0.17	-0.33

Click cells to compare fundamentals

Teladoc Account Relationship Matchups

Teladoc income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	78.1M	219.6M	270.6M	351.3M	382.8M	402.0M
Interest Expense	60.5M	80.4M	9.3M	22.3M	23.8M	25.2M
Selling General Administrative	506.7M	438.0M	449.9M	464.7M	435.5M	256.2M
Selling And Marketing Expenses	380.2M	667.3M	850.7M	902.6M	705.8M	371.1M
Total Revenue	1.1B	2.0B	2.4B	2.6B	2.6B	2.7B
Gross Profit	703.1M	1.4B	1.7B	1.8B	1.8B	1.9B
Other Operating Expenses	1.5B	2.3B	2.6B	2.9B	3.6B	3.8B
Operating Income	(418.2M)	(239.0M)	(13.2B)	(248.6M)	(1.0B)	(1.1B)
Ebit	(516.1M)	(304.3M)	(13.7B)	(197.3M)	(969.9M)	(1.0B)
Research Development	164.9M	311.9M	333.6M	348.5M	307.3M	322.6M
Ebitda	(438.0M)	(84.7M)	(13.5B)	154.0M	(587.0M)	(616.4M)
Cost Of Revenue	390.8M	650.3M	744.0M	760.0M	751.3M	788.8M
Total Operating Expenses	1.1B	1.6B	1.9B	2.1B	2.8B	3.0B
Income Before Tax	(576.0M)	(384.7M)	(13.7B)	(219.6M)	(993.7M)	(1.0B)
Total Other Income Expense Net	(69.6M)	(119.0M)	(26.9B)	28.9M	27.2M	28.6M
Net Income	(485.1M)	(428.8M)	(13.7B)	(220.4M)	(1.0B)	(1.1B)
Income Tax Expense	(90.9M)	44.1M	(3.8M)	760K	7.6M	8.0M
Net Income From Continuing Ops	(485.1M)	(428.8M)	(13.7B)	(220.4M)	(1.0B)	(1.1B)
Non Recurring	6.6M	88.2M	26.6M	13.4B	15.4B	16.2B
Net Income Applicable To Common Shares	(98.9M)	(485.1M)	(428.8M)	(13.7B)	(12.3B)	(11.7B)
Tax Provision	(90.9M)	44.1M	(3.8M)	760K	7.6M	8.0M
Net Interest Income	(60.5M)	(80.4M)	(9.3M)	24.5M	33.3M	34.9M
Reconciled Depreciation	78.1M	219.6M	270.6M	351.3M	382.8M	192.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:

How To Invest In Teladoc

Details

Is Teladoc Stock a good investment?

Details

What is Teladoc's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.87)

Revenue Per Share

15.065

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.03)

Return On Equity

(0.52)

The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Teladoc Historical Income Statement

About Teladoc Income Statement Analysis

Teladoc Income Statement Chart

Total Revenue

Other Operating Expenses

Cost Of Revenue

Teladoc income statement Correlations

Teladoc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Teladoc income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Gross Profit
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income

Extraordinary Items	- 0.74	Interest Income
Extraordinary Items	- 0.71	Total Operating Expenses
Extraordinary Items	- 0.69	Non Recurring
Extraordinary Items	- 0.68	Other Operating Expenses
Net Interest Income	- 0.67	Interest Expense
Extraordinary Items	- 0.67	Depreciation And Amortization